Securities code: Jafron Biomedical Co.Ltd(300529) securities abbreviation: Jafron Biomedical Co.Ltd(300529) Announcement No.: 2022046 bond Code: 123117 bond abbreviation: Jianfan convertible bond
Jafron Biomedical Co.Ltd(300529)
Announcement of resolutions of the 32nd meeting of the 4th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
Jafron Biomedical Co.Ltd(300529) (hereinafter referred to as “the company”) the 32nd meeting of the 4th board of supervisors was held by means of on-site voting and communication voting in the company’s conference room on April 13, 2022. Three people should attend this meeting and three actually attended. The notice of this meeting was delivered to all supervisors by hand on April 8, 2022. The meeting was presided over by Mr. Peng Xiaohong, chairman of the board of supervisors. The meeting was held in accordance with the relevant provisions of the company law of the people’s Republic of China and the articles of association.
2、 Deliberation at the meeting of the board of supervisors
After careful discussion, the supervisors attending the meeting deliberated and voted on the following proposals:
1. The full text of the report for the first quarter of 2022 was considered and adopted
The board of supervisors believes that the procedures for the full text of the company’s report for the first quarter of 2022 prepared and reviewed by the board of directors comply with laws, administrative regulations and relevant provisions of the CSRC. The contents of the report truly, accurately and completely reflect the operation of the company, and there are no false records, misleading statements or major omissions.
The full text of the company’s report for the first quarter of 2022 is published on cninfo.com, the gem information disclosure website designated by the CSRC on the same day（ http://www.cn.info.com.cn. ）Announcement.
Voting: 3 in favor, 0 against and 0 abstention. The bill was passed.
It is hereby announced.
Jafron Biomedical Co.Ltd(300529) board of supervisors April 14, 2022
